James Saccaro, a former officer of GE HealthCare Technologies Inc., filed a Form 144 notice on November 4, 2026, disclosing a proposed sale of 78,348 shares of common stock on NASDAQ:GEHC.

Key Highlights

  • Proposed seller: James Saccaro, identified in the filing as a former officer of GE HealthCare Technologies Inc.
  • Shares proposed for sale: 78,348 shares of common stock, with an aggregate market value of $6,731,613.46 according to the filing.
  • Source of shares: Two stock option exercises on November 4, 2026, for 54,472 shares and 23,876 shares respectively, both acquired from GE HealthCare Technologies Inc.
  • Approximate date of sale: November 4, 2026, through broker UBS Financial Services Inc., located at 1000 Harbor Blvd, 3rd Floor, Weehawken, NJ 07086.
  • Total shares outstanding: 452,137,831 shares of common stock, as reported in the filing.
  • Prior three-month sales: The filing reports nothing to report for securities sold during the past three months.

Saccaro's Proposed Rule 144 Sale Following Stock Option Exercises

According to the Form 144 filing submitted on November 4, 2026, James Saccaro, a former officer of GE HealthCare Technologies Inc. (NASDAQ:GEHC), proposed to sell 78,348 shares of the company's common stock. The filing lists UBS Financial Services Inc. as the named broker for the proposed transaction, with the approximate date of sale given as November 4, 2026.

The filing discloses that the shares proposed for sale were acquired through two separate stock option exercise transactions, both dated November 4, 2026. The first exercise involved 54,472 shares and the second involved 23,876 shares, with both acquisitions attributed to GE HealthCare Technologies Inc. as the entity from whom the shares were acquired. The combined aggregate market value of the 78,348 shares is stated in the filing as $6,731,613.46.

The notice was signed by Joseph Cassidy, described in the filing as acting for UBS Financial Services Inc. as attorney-in-fact for James Saccaro. The filing states that no securities of the issuer were sold by Saccaro during the past three months. GE HealthCare Technologies Inc. is headquartered at 500 W. Monroe Street, Chicago, Illinois 60661, with SEC File Number 001-41528.

What Was Disclosed

A Form 144 notice was filed on November 4, 2026, disclosing a proposed sale of 78,348 GE HealthCare common shares by former officer James Saccaro, sourced from two stock option exercises, with an aggregate market value of $6,731,613.46.